[go: up one dir, main page]

BR9612800A - Pharmaceutical dosage form for colonic distribution. - Google Patents

Pharmaceutical dosage form for colonic distribution.

Info

Publication number
BR9612800A
BR9612800A BR9612800-3A BR9612800A BR9612800A BR 9612800 A BR9612800 A BR 9612800A BR 9612800 A BR9612800 A BR 9612800A BR 9612800 A BR9612800 A BR 9612800A
Authority
BR
Brazil
Prior art keywords
dosage form
colon
coating material
polymeric coating
distribution
Prior art date
Application number
BR9612800-3A
Other languages
Portuguese (pt)
Inventor
Robert Gary Kelm
Gary Lee Manring
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Priority to BR9612800-3A priority Critical patent/BR9612800A/en
Priority claimed from PCT/US1996/018257 external-priority patent/WO1998022095A1/en
Publication of BR9612800A publication Critical patent/BR9612800A/en

Links

Landscapes

  • Medicinal Preparation (AREA)

Abstract

Patente de Invenção:<B>"FORMA DE DOSAGEM FARMACêUTICA PARA DISTRIBUIçãO COLÈNICA"<D>. A presente invenção se refere a uma composição farmacêutica em uma forma de dosagem em nidade para administração peroral em um ser humano ou animal inferior, tendo um trato gastroinstetinal compreendendo um intestino delgado e um cólon com um lúmen tendo uma entrada ao cólon a partir do intestino delgado, compreendendo: a. uma quantidade segura e efetiva de um agente terapêutico incorporado ou revestido sobre a superfície de uma forma de dosagem selecionada do grupo consistindo de um substrato esférico, um substrato elíptico, uma cápsula rígida, ou um tablete comprimido, com um diâmetro máximo de cerca de 3mm a cerca de 10 mm; e b. um material de revestimento polimérico entérico; em que a forma de dosagem possui uma superfície lisa isenta de bordas ou curvas cortantes; o substrato elíptico e a cápsula rígida possuem uma proporção dos diâmetros longo para curto de não mais do que cerca de 1,5; o agente terapêutico é liberado em um ponto próximo à entrada ou dentro do cólon; o material de revestimento polimérico entérico começa a se dissolver em um meio aquoso em um pH entre cerca de 5 a cerca de 6,3; e o material de revestimento polimérico entérico possui uma espessura de revestimento de pelo menos cerca de 250<109>m.Invention Patent: <B> "PHARMACEUTICAL DOSAGE FORM FOR COLOGNICAL DISTRIBUTION" <D>. The present invention relates to a pharmaceutical composition in a standard dosage form for peroral administration in a human or lower animal, having a gastroinstetinal tract comprising a small intestine and a colon with a lumen having an entry to the colon from the intestine. slender, comprising: a. a safe and effective amount of a therapeutic agent incorporated or coated on the surface of a dosage form selected from the group consisting of a spherical substrate, an elliptical substrate, a rigid capsule, or a compressed tablet, with a maximum diameter of about 3mm at about 10 mm; and b. an enteric polymeric coating material; wherein the dosage form has a smooth surface free of sharp edges or curves; the elliptical substrate and the rigid capsule have a ratio of long to short diameters of no more than about 1.5; the therapeutic agent is released at a point near the entrance or inside the colon; the enteric polymeric coating material begins to dissolve in an aqueous medium at a pH between about 5 to about 6.3; and the enteric polymeric coating material has a coating thickness of at least about 250 µm.

BR9612800-3A 1996-11-15 1996-11-15 Pharmaceutical dosage form for colonic distribution. BR9612800A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
BR9612800-3A BR9612800A (en) 1996-11-15 1996-11-15 Pharmaceutical dosage form for colonic distribution.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/US1996/018257 WO1998022095A1 (en) 1996-11-15 1996-11-15 Pharmaceutical dosage form for colonic delivery
BR9612800-3A BR9612800A (en) 1996-11-15 1996-11-15 Pharmaceutical dosage form for colonic distribution.

Publications (1)

Publication Number Publication Date
BR9612800A true BR9612800A (en) 2000-03-28

Family

ID=25664823

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9612800-3A BR9612800A (en) 1996-11-15 1996-11-15 Pharmaceutical dosage form for colonic distribution.

Country Status (1)

Country Link
BR (1) BR9612800A (en)

Similar Documents

Publication Publication Date Title
DE69630375D1 (en) PHARMACEUTICAL DOSAGE FORM FOR RELEASE IN THE COLON
BR9713256A (en) Bisacodyl dosage form with multiple enteric polymeric coating for colonic release
DE69619668D1 (en) PHARMACEUTICAL DOSAGE FORM WITH MULTIPLE GAROL-SOLUBLE POLYMER COATING FOR ACTIVE SUBSTANCE DELIVERY IN THE COLON
ATE225165T1 (en) PHARMACEUTICAL PREPARATION IN THE FORM OF A COATED CAPSULE RELEASED IN THE LOWER PART OF THE DIGESTIVE TRACT
BR0211317A (en) System for controlled drug release through gastric retention
BR0103033A (en) Pharmaceutical particles of masked flavor
BR0007454A (en) Implant devices and methods with biocompatible drug transfer controlled deliberation in the ocular system
IL84167A (en) Oral delivery of bioactive agents to and through the peyer&#39;s patch by use of microencapsulation
ZA952169B (en) Pharmaceutical compositions
ES2140641T3 (en) DRUGS AND / OR NUTRITIONAL MICROCAPSULES FOR ORAL ADMINISTRATION.
GEP20032912B (en) Enteric Coated Pharmaceutical Tablets and Method of Manufacturing
ATE380022T1 (en) MULTIPARTICULAR MEDICINAL FORM CONTAINING AT LEAST TWO DIFFERENTLY COATED PELLET FORMS
DE769938T1 (en) Multi-layer capsules with a silicone resin filling
PT825858E (en) DEPENDENT TIME-RELEASING CAPSULES CONTAINING POLYINSATURATED ACIDS OMEGA-3 FOR THE TREATMENT OF INFLAMMATORY DISEASE OF THE INTESTINE
TR200100569T2 (en) Oral liquid compositions adhering to the mucosa (mucoadhesive)
ATE245450T1 (en) ADHESIVE MICROBEADS COMPREHENSIVE COMPOSITION FOR MEDICINAL ADMINISTRATION
RU99108461A (en) DOSAGE FORM FOR ORAL ADMINISTRATION WITH DELAYED IMMEDIATE RELEASE AND METHOD FOR PREPARING IT
NZ235807A (en) Controlled release pellet formulation (core coated with or comprising a glucocorticosteroid, and a polymeric outer coating); capsules containing pellets; and use in treating bowel disease
KR880003617A (en) Oral solid formulation and preparation method thereof
ATE290855T1 (en) LAMINAR MEDICINAL FORM
NO973950L (en) Oral composition for controlled release in the lower gastrointestinal tract
CA2142982A1 (en) Articles for sustained release of medications
EP0804172A4 (en)
PT96921B (en) INTERMITTENT RELEASE DEVICE
AU602818B2 (en) Veterinary devices

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Free format text: MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US)

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A,8, 9A E 10A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1860 DE 29/08/2006.